Results 251 to 260 of about 608,665 (299)
Some of the next articles are maybe not open access.
Immunoglobulin degradation and D-penicillamine action
Biochemical and Biophysical Research Communications, 1985Treatment of human IgG with pancreatic elastase gave a product of higher molecular weight than IgG. Its formation was inhibited by blocking IgG sulfhydryl groups with iodoacetamide. Incubation of the high molecular weight product with either glutathione or D-penicillamine yielded Fab- and Fc-like fragments.
openaire +2 more sources
Immunoglobulin D multiple myeloma.
Chang Gung medical journal, 2000Immunoglobulin D (IgD) multiple myeloma (MM) is rare, accounting for less than 2% of all patients with MM in Western countries. In Taiwan, the frequency and clinicopathologic features of IgD MM have not yet been reported.The clinicopathologic features and treatment outcome of patients with IgD MM diagnosed between January 1, 1982, and December 31, 1998,
T L, Lin +5 more
openaire +1 more source
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly
Nihon rinsho. Japanese journal of clinical medicine, 2010
Nobuhiko, Kubo +2 more
openaire +1 more source
Nobuhiko, Kubo +2 more
openaire +1 more source